Skip to content

ANI Versus Standard Care in Surgical Patients Receiving Balanced Sevoflurane-Fentanyl Anesthesia

A Prospective, Randomized, PACU Blinded Study to Compare ANI-guided Analgesic Administration Versus Standard Care in Surgical Patients Receiving Balanced Sevoflurane-Fentanyl Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03684590
Enrollment
102
Registered
2018-09-25
Start date
2019-07-30
Completion date
2023-03-06
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain

Brief summary

This study aims to be a randomized, controlled study of ANI-guided opioid administration versus standard clinical practice in surgical patients undergoing general anesthesia with balanced sevoflurane-fentanyl. Patients will be randomly assigned to 2 groups- ANI vs. standard care. The intraoperative and postoperative management of all patients will be standardized by protocol. The PACU nurses and postop assessor will be blinded as to which group the patient is in.

Interventions

DEVICEANI-guided opioid administration

Intraoperative opioid will be administered guided by analgesia nociceptive index (ANI) values measured by ANI monitor (MetroDoloris Medical Systems, Lille, France)

OTHERStandard opioid administration

Intraoperative opioid will be administered according to standard practice during surgery.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-75 years old * ASA 1-2 * BMI 19-35 kg/m2 * Patients undergoing surgery with general anesthesia with sevoflurane- fentanyl * Planned abdominal or spinal surgery lasting 1-3 hours * Willing and able to consent in English or Spanish * No current history of advanced pulmonary or cardiovascular disease

Exclusion criteria

* Age less than 18 or older than 75 * Patient does not speak English or Spanish * Patient refusal * Monitored anesthesia care (MAC) or regional anesthesia planned * Pregnant or nursing women * Stat (emergent) cases * ECG rhythm other than regular sinus rhythm * Implanted pacemakers * On antimuscarinic agents, alpha 2 agonists, antiarrhythmics, or beta blockers * Presence of pacemaker * Autonomic nervous system disorder * Use of chronic opioids

Design outcomes

Primary

MeasureTime frameDescription
The Incidence of Severe Postoperative Painpostoperative recovery period, an average of 1 hourThe primary outcome will be the NRS pain scores reported during recovery

Secondary

MeasureTime frameDescription
The Incidence of Pain Medication UsePerioperative and postoperative recovery periodThe total amounts of opioid analgesics administered in the operating room (OR) and post-anesthesia care unit (PACU)
The Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)Postoperative recovery periodThe incidence of nausea/vomiting reported during recovery
The Incidence of Minimal PainPostoperative recovery periodThe percent of subjects with minimal pain (NPS \< 3) in post-anesthesia care unit (PACU)

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Opioid Administration
Intraoperative opioid will be administered by guiding standard practice Standard opioid administration: Intraoperative opioid will be administered according to standard practice during surgery.
49
ANI-guided Opioid Administration
Intraoperative opioid will be administered based on the analgesia nociceptive index (ANI) ANI-guided opioid administration: Intraoperative opioid will be administered guided by analgesia nociceptive index (ANI) values measured by ANI monitor (MetroDoloris Medical Systems, Lille, France)
53
Total102

Baseline characteristics

CharacteristicStandard Opioid AdministrationANI-guided Opioid AdministrationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants1 Participants1 Participants
Age, Categorical
Between 18 and 65 years
49 Participants52 Participants101 Participants
Age, Continuous42.69 years45.31 years43.87 years
Ethnicity (NIH/OMB)
Hispanic or Latino
31 Participants37 Participants68 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants16 Participants34 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Region of Enrollment
United States
49 participants53 participants102 participants
Sex: Female, Male
Female
49 Participants52 Participants101 Participants
Sex: Female, Male
Male
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 53
other
Total, other adverse events
0 / 490 / 53
serious
Total, serious adverse events
0 / 490 / 53

Outcome results

Primary

The Incidence of Severe Postoperative Pain

The primary outcome will be the NRS pain scores reported during recovery

Time frame: postoperative recovery period, an average of 1 hour

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard Opioid AdministrationThe Incidence of Severe Postoperative Pain49 Participants
ANI-guided Opioid AdministrationThe Incidence of Severe Postoperative Pain53 Participants
Secondary

The Incidence of Minimal Pain

The percent of subjects with minimal pain (NPS \< 3) in post-anesthesia care unit (PACU)

Time frame: Postoperative recovery period

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard Opioid AdministrationThe Incidence of Minimal Pain12 Participants
ANI-guided Opioid AdministrationThe Incidence of Minimal Pain22 Participants
Secondary

The Incidence of Pain Medication Use

The total amounts of opioid analgesics administered in the operating room (OR) and post-anesthesia care unit (PACU)

Time frame: Perioperative and postoperative recovery period

ArmMeasureValue (MEAN)Dispersion
Standard Opioid AdministrationThe Incidence of Pain Medication Use224.1 microgramsStandard Deviation 140.5
ANI-guided Opioid AdministrationThe Incidence of Pain Medication Use294.4 microgramsStandard Deviation 170.3
Secondary

The Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)

The incidence of nausea/vomiting reported during recovery

Time frame: Postoperative recovery period

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard Opioid AdministrationThe Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)0 Participants
ANI-guided Opioid AdministrationThe Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026